Management of Patients With Early Stage Lung Cancer - Why Do Some Patients Not Receive Treatment With Curative Intent?
aut.relation.articlenumber | 109 | en_NZ |
aut.relation.issue | 1 | en_NZ |
aut.relation.journal | BMC Cancer | en_NZ |
aut.relation.volume | 20 | en_NZ |
aut.researcher | Drabsch, Julie | |
dc.contributor.author | Lawrenson, R | en_NZ |
dc.contributor.author | Lao, C | en_NZ |
dc.contributor.author | Brown, L | en_NZ |
dc.contributor.author | Moosa, L | en_NZ |
dc.contributor.author | Chepulis, L | en_NZ |
dc.contributor.author | Keenan, R | en_NZ |
dc.contributor.author | Kidd, J | en_NZ |
dc.contributor.author | Middleton, K | en_NZ |
dc.contributor.author | Conaglen, P | en_NZ |
dc.contributor.author | De Groot, C | en_NZ |
dc.contributor.author | Aitken, D | en_NZ |
dc.contributor.author | Wong, J | en_NZ |
dc.date.accessioned | 2021-01-11T21:17:38Z | |
dc.date.available | 2021-01-11T21:17:38Z | |
dc.date.copyright | 2020 | en_NZ |
dc.date.issued | 2020 | en_NZ |
dc.description.abstract | BACKGROUNDS: This study aims to understand the factors that influence whether patients receive potentially curative treatment for early stage lung cancer. A key question was whether indigenous Māori patients were less likely to receive treatment. METHODS: Patients included those diagnosed with early stage lung cancer in 2011-2018 and resident in the New Zealand Midland Cancer Network region. Logistic regression model was used to estimate the odds ratios of having curative surgery/ treatment. The Kaplan Meier method was used to examine the all-cause survival and Cox proportional hazard model was used to estimate the hazard ratio of death. RESULTS: In total 419/583 (71.9%) of patients with Stage I and II disease were treated with curative intent - 272 (46.7%) patients had curative surgery. Patients not receiving potentially curative treatment were older, were less likely to have non-small cell lung cancer (NSCLC), had poorer lung function and were more likely to have an ECOG performance status of 2+. Current smokers were less likely to be treated with surgery and more likely to receive treatment with radiotherapy and chemotherapy. Those who were treated with surgery had a 2-year survival of 87.8% (95% CI: 83.8-91.8%) and 5-year survival of 69.6% (95% CI: 63.2-76.0%). Stereotactic ablative body radiotherapy (SABR) has equivalent effect on survival compared to curative surgery (hazard ratio: 0.77, 95% CI: 0.37-1.61). After adjustment we could find no difference in treatment and survival between Māori and non-Māori. CONCLUSIONS: The majority of patients with stage I and II lung cancer are managed with potentially curative treatment - mainly surgery and increasingly with SABR. The outcomes of those being diagnosed with stage I and II disease and receiving treatment is positive with 70% surviving 5 years. | en_NZ |
dc.identifier.citation | BMC Cancer, 20(1), 109. | |
dc.identifier.doi | 10.1186/s12885-020-6580-6 | en_NZ |
dc.identifier.issn | 1471-2407 | en_NZ |
dc.identifier.issn | 1471-2407 | en_NZ |
dc.identifier.uri | https://hdl.handle.net/10292/13905 | |
dc.publisher | BioMed Central | en_NZ |
dc.relation.uri | https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-6580-6 | |
dc.rights | © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | |
dc.rights.accessrights | OpenAccess | en_NZ |
dc.subject | Lung cancer; Non-small cell lung cancer; Thoracic surgery; Stereotactic ablative body radiotherapy; Smoking | |
dc.title | Management of Patients With Early Stage Lung Cancer - Why Do Some Patients Not Receive Treatment With Curative Intent? | en_NZ |
dc.type | Journal Article | |
pubs.elements-id | 371199 | |
pubs.organisational-data | /AUT | |
pubs.organisational-data | /AUT/Health & Environmental Science | |
pubs.organisational-data | /AUT/Health & Environmental Science/Clinical Sciences | |
pubs.organisational-data | /AUT/Health & Environmental Science/Nursing |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Lawrenson_2020_Management of patients.pdf
- Size:
- 868.64 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
Loading...
- Name:
- AUT Grant of Licence for Tuwhera Aug 2018.pdf
- Size:
- 276.29 KB
- Format:
- Adobe Portable Document Format
- Description: